Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients.

MLA

Powrózek, T., et al. “Methylation of the DCLK1 Promoter Region in Circulating Free DNA and Its Prognostic Value in Lung Cancer Patients.” Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, vol. 18, no. 4, Apr. 2016, pp. 398–404. EBSCOhost, https://doi.org/10.1007/s12094-015-1382-z.

APA

Powrózek, T., Krawczyk, P., Nicoś, M., Kuźnar-Kamińska, B., Batura-Gabryel, H., & Milanowski, J. (2016). Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients. Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 18(4), 398–404. https://doi.org/10.1007/s12094-015-1382-z

Chicago

Powrózek, T, P Krawczyk, M Nicoś, B Kuźnar-Kamińska, H Batura-Gabryel, and J Milanowski. 2016. “Methylation of the DCLK1 Promoter Region in Circulating Free DNA and Its Prognostic Value in Lung Cancer Patients.” Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 18 (4): 398–404. doi:10.1007/s12094-015-1382-z.